Fluoro-2-Deoxyglucose-Positron Emission Tomography/Computed Tomography in the Diagnosis and Management of Adrenocortical Carcinoma: A 10-Year Experience from a Tertiary Care Institute.

Krishnaraju, Venkata Subramanian; Kumar, Rajender; Subramanian, Karthikeyan; Mittal, Bhagwant Rai; Singh, Harmandeep; Chatterjee, Debajyoti; Walia, Rama

Krishnaraju, Venkata Subramanian; Kumar, Rajender; Subramanian, Karthikeyan; Mittal, Bhagwant Rai; Singh, Harmandeep; Chatterjee, Debajyoti; Walia, Rama.

Afiliação

Krishnaraju VS; Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Kumar R; Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Subramanian K; Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Mittal BR; Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Singh H; Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Chatterjee D; Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Walia R; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Indian J Nucl Med ; 37(3): 227-235, 2022.

Article em En | MEDLINE | ID: mdl-36686301

Palavras-chave

Adrenocortical carcinoma; fluorodeoxyglucose F18; positron-emission tomography

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Indian J Nucl Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google